Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,816,061 papers from all fields of science
Search
Sign In
Create Free Account
spherons
Known as:
Spheron S
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Polymethacrylic Acids
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
About long-range interaction of spheroidal solitons in scalar field nonlinear model
A. Chernitskii
2017
Corpus ID: 118954587
The nonlinear scalar field model of space-time film (Born – Infeld type nonlinear scalar field model) is considered. Its…
Expand
2000
2000
Spherons and Alzheimer's disease: Biochemical, immunological and cell biological studies
P. Averback
,
J. Fitzpatrick
,
L. Iversen
,
D. Kaufman
,
D. Morse
2000
Corpus ID: 90998634
Review
1998
Review
1998
Spherons as a drug target in Alzheimer's disease.
P. Averback
Drug News and Perspectives
1998
Corpus ID: 20765240
Spherons are unique brain entities that are causally linked to the amyloid plaques (SPs [senile plaques]) of Alzheimer's disease…
Expand
1991
1991
Transition from one revolving cluster to two revolving clusters in the ground-state rotational bands of nuclei in the lanthanon region.
L. Pauling
Proceedings of the National Academy of Sciences…
1991
Corpus ID: 7020262
Whereas 234(92)U142 and other actinon nuclei have ground-state bands that indicate that each nucleus consists of a sphere and a…
Expand
1974
1974
Resonance between a Prolate and a Superprolate Structure of the Er Nucleus.
L. Pauling
,
J. Blethen
Proceedings of the National Academy of Sciences…
1974
Corpus ID: 38096908
Observed energy levels of (162)Er from the normal state J = 0 to the excited rotational state J = 18 correspond to values of the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE